Israeli Scientists Say They’ll Have Cancer Cure in the Next Year: Report | National News
A team of scientists in Israel says they’ll likely have discovered a cure for cancer in the next year.
The Jerusalem Post reports the small team led by Accelerated Evolution Biotechnologies CEO Ilan Morad thinks it might have found the first complete cure – a treatment akin to a cancer antibiotic. The treatment, called MuTaTo (multi-target toxin), uses a combination of cancer-targeting peptides and a toxin that specifically kills cancer cells. And, because the cells would be killed, patients could likely stop treatment after a number of weeks and not need a drug cocktail throughout their lives, according to the report.
Dan Aridor, the chairman of the company’s board, is confident in the team’s progress.
“We believe we will offer in a year’s time a complete cure for cancer,” Aridor told the paper. He continued: “Our cancer cure will be effective from Day One, will last a duration of a few weeks and will have no or minimal side effects at a much lower cost than most other treatments on the market.”
Morad told the Post that his team has concluded its first exploratory experiment on mice with promising results. The experiment showed inhibited human cancer cell growth and had no effect on healthy mice cells, according to the paper. The company will soon begin clinical trials that could be completed within “a few years” and would make the treatment available in specific cases, the Post reports.
The Photos You Should See – Jan. 2019
Morad said researchers “made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.”
The team said the treatment will eventually be personalized, and patients would receive a specific molecule cocktail needed for an effective treatment.
In 2018, the International Agency for Research on Cancer estimated there were 17 million new cancer cases and 9.5 million cancer deaths worldwide. That global burden is supposed to grow significantly by 2040, according to the American Cancer Society.